Eli Lilly Beats Zyprexa Failure-To-Warn Suit In 8th Circ.

Law360, New York (March 10, 2014, 5:15 PM EDT) -- The Eighth Circuit on Monday upheld a victory for Eli Lilly & Co. in a lawsuit claiming it failed to adequately warn of the risks of long-term use of the antipsychotic drug Zyprexa, backing a lower court's exclusion of expert testimony.

The ruling supported an Arkansas federal judge's exclusion of psychiatrist Stefan Kruszewski's opinion that 15 percent of Zyprexa users will develop tardive dyskinesia, an involuntary movement disorder, after taking the drug for three years. Plaintiff Timothy Boehm claimed he developed the condition after taking Zyprexa...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Timothy Boehm v. Eli Lilly & Company


Case Number

13-1350

Court

Appellate - 8th Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

February 14, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.